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Introduction: We fabricated custom-made artiﬁcial bones using three-dimensionally layered
manufacturing (3D printing) process, and have applied them to patients with facial deformities. We
termed this novel artiﬁcial bone the “CT-bone”. The aim of the present study was to evaluate the middle-
and long-term safety and effectiveness of the CT-bones after transplantation.
Methods: The subject areas involved were 23 sites of 20 patients with facial bone deformities due to
congenital abnormality, tumor, or trauma. The CT-bones were used for augmentation; they were eval-
uated by CT images, minimally for 1 year and maximally for 7 years and 3 months (3 years and 1 month
on average) after transplantation.
Results: No serious systemic events due to the CT-bone graft were found during the observation period
(1 year postoperatively). In 4 sites of 4 patients, the CT-bones were removed due to local infection of the
surgical wounds at 1e5 years postoperatively. Compatibility of the shapes between the CT-bone and the
recipient bone was conﬁrmed to be good during the operation in all of the 20 cases, implying that the CT-
bones could be easily installed onto the recipient sites. During the CT evaluation (<7 years and 3 months),
no apparent chronological change was seen in the shape of the CT-bones. Sufﬁcient bone union was
conﬁrmed in 19 sites. The inner CT values of the CT-bones increased in all the sites. The longer the
postoperative period, greater increases in the CT values of the CT-bones tended to be observed.
Conclusions: The CT-bone showed maintenance of the original shape and good bone replacement, based
on the middle- and long-term follow-ups. In the future, we would make an intelligent type of artiﬁcial
bones in which bone regeneration is induced by gradually releasing angiogenesis-inducing factors and/or
bone-regeneration-inducing factors at the three-dimensionally controlled positions.
© 2016, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).omputed tomography; HA,
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Treatments for facial deformities include dermal fat graft, sili-
cone implant, autologous bone graft, and artiﬁcial bone graft [1].
Especially, for facial bone deformities and defects, the autologous
bone graft has currently been the gold standard as the treatment.
However, it has problems such as invasiveness to the donor site and
a restriction in volume of the bones that can be harvested from the
patients [2]. Moreover, the resorption of transplanted bone is
known. Although allogenic bone graft has been clinically used all
over the world, it is not popular in Japan, which may reﬂect thesting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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tries. There are also concerns about problems such as infectious
diseases and ethical issues associated with the use of another
person's bones [3]. In addition, both the autologous bone graft and
the allogenic one have to be shaped to ﬁt the recipient sites during
surgery. It takes a long time to make a complicated shape [4].
In order to solve these problems, artiﬁcial bones using HA and/
or calcium phosphate have been developed [5]. These are not
applicable to sites subject to pressure from the skin and/or the
mucosa after the transplantation, when they are supplied as
granules or paste. To maintain their shape, they must be block-
shaped, which also requires caving during surgery, leading to a
substantial prolongation of the operation time and the difﬁculty in
making complicated shapes.
Staffa et al. [6,7] reported a method of engrafting a customized
artiﬁcial bone preoperatively fabricated by a matching center in
repair for a cranial bone defect, with satisfactory medium- and
long-term outcomes. In this method, an artiﬁcial bone is formed in
a shape compatible to the defect referring to a full size of three-
dimensional model fabricated by rapid prototyping technology
based on CT images. However, these artiﬁcial bones are likely to
require a considerably long time to be replaced by host bones,
because they are sintered porous HA blocks with a high crystal-
linity. Moreover, it is impossible to provide internal structures such
as interconnecting pores for blood vessel and cell migration. Cao
et al. [8] also reported the clinical application of custom-made
artiﬁcial bones fabricated from HA and methacrylate resins to the
cranio-maxillofacial region. They applied rapid prototyping tech-
nology for the fabrication. However, it is impossible to provide in-
ternal structures because the bones are formed by casting amixture
of HA and methacrylate resins in a mold. In addition, replacement
by autologous tissues cannot be expected due to the remaining
resins.
In order to enable to replace artiﬁcial bones to host's own bones
and to provide internal structures within the artiﬁcial bones, we
fabricated custom-made artiﬁcial bones using a new technique by a
three-dimensionally layered manufacturing (3D printing) process,
and applied them to patients with facial deformities [9e11]. We
called this novel artiﬁcial bone IPCAB in our previous report [9]; we
currently term it “CT-bone”.
This artiﬁcial bone is directly fabricated by a three-
dimensionally layered manufacturing process using an inkjet
printer, allowing us to provide complicated shapes such as over-
hangs and internal structures. Therefore, this is likely to be very
suitable for the reproduction of the complicated shapes of the
maxillofacial region [12]. Moreover, rapid replacement by living
bone can be expected because unsintered calcium phosphate, a-
TCP, is the major component. No method has been reported up to
date except for our technology, which directly forms artiﬁcial
bones for clinical use using the rapid prototyping technology
[9e11,13].
This study aimed to evaluate the medium- and long-term safety
and effectiveness of the CT-bones after transplantation. The CT-
bones were used in the augmentation of facial bone deformities,
while they were evaluated by the CT images for maximum of 7
years and 3 months after transplantation.
2. Methods
2.1. Patients
The subject areas involved were 23 sites of 20 patients with non
weight bearing facial bone deformities (e.g., maxilla, mandible,
chin, frontal bone) due to a congenital abnormality, tumor, or
trauma. As subjects of this clinical trial and study, they underwentCT-bone grafts in our department between March 2006 and
September 2009 (Table 1).
All patients were provided with informed consent and under-
stood the risks of the study and the potential for no beneﬁt. The
study was approved by the Ethical Committee of the Faculty of
Medicine at the University of Tokyo (approval no.1310), and Clinical
Research Support Center at the University of Tokyo (approval code:
3DB-01/CT-1).
2.2. Design and fabrication of CT-bone
The CT-bones were fabricated according to our previous reports
[9e11,13,14]. All of the CT images were generated by a helical CT
scanner (Aquilion®, Toshiba, Tokyo, Japan) with uniﬁed parame-
ters; reconstruction interval of 1 mm; tube current of 300 mA at
120 kV.
Using the pre-surgical CT scanning data, a three-dimensional
model was fabricated from plaster. On this three-dimensional
model, the surgeon performed a surgical simulation using wax
provided with radiopacity for a better contrast (PCT/JP2007/
000885) [15]. To increase the radiopacity without affecting the
good handling, dental parafﬁn wax was mixed with rutile-type ti-
tanium oxide at the ratio of 80:3. Next, to extract the design data of
the CT-bone from this simulationmodel, themodel underwent a CT
scan again. The DICOM data were acquired from the CT images and
converted to STL ﬁles. The CT-bonewas then designedwith internal
structures such as holes for ﬁxation by absorbable sutures using
CAD. This ﬁnal design was output to a 3D inkjet printer (Z406 3D
color printer, Z-Corporation, Burlington, MA, USA), which sprayed
hardening liquid onto the a-TCP powder (Taihei Chemical Indus-
trial, Osaka, Japan). This method can manufacture an approximate
0.1 mm thick thin layer at each step. This step was repeated to
overlay the thin layers for the fabrication of the speciﬁed CT-bone
design. The hardening liquid is composed of 5% sodium chon-
droitin sulfate (Seikagaku, Tokyo, Japan), 12% disodium succinate
(Wako, Osaka, Japan), and 83% distilled water (Otsuka Pharma-
ceuticals, Tokyo, Japan). The CT-bones fabricated by the three-
dimensionally layered manufacturing process were immersed in
the hardening liquid for an additional 6 h to increase their me-
chanical strength.
The CT-bones were sterilized by autoclaving (121 C, 30 min).
After the sterilization, the bones were dried for 6 h at 75 C.
2.3. Surgical procedures and follow-ups
The CT-bone grafting was performed using an intraoral or
extraoral approach under general anesthesia in all cases. An oral
mucosa or skin incision was made, followed by subperiosteal
dissection (or dissection under the periosteum-like tissue) for
exposure of the recipient bone. The CT-bone was engrafted in the
designated position and ﬁxed onto the host bone using absorb-
able sutures (2-0 Vicryl®, Johnson & Johnson, USA) when possible.
For closing of the incision, the oral mucosa or skin was sutured
after suturing the periosteum (or periosteum-like tissue). All of
the surgical procedures were only grafts for augmentation
purposes.
The presence or absence of any adverse event and the level of
satisfaction (yes or no) were surveyed using interviews and ex-
aminations by a physician. The CT scan was also performed pre-
operatively, immediately postoperatively, at half a year and at 1
year postoperatively. As observation period, we primarily evaluated
clinical results of the CT-bone at 1 year. Even 1 year after the
operation, patients who could attend our hospital underwent
outpatient medical examination for follow-up and, when required,
CT scans, in order to check safety or adverse events.
Table 1
Patient demographics. In 3 cases, the CT-bones were grafted onto 2 sites (Case 1, Case 4, Case 13). Volumes of CT-bones were measured in the CAD data.







Removal Satisfaction Method of
ﬁxation
1-1 26 F Right maxillary and Right maxilla 7.4 2 h 10 min 7y 3m e Yes No ﬁxed
1-2 mandibular hypoplasia Right mandibule 8.3 1y 2m No ﬁxed
2 55 F Left mandibular deformity after reconstruction Left mandibule 15.8 4 h 2y e Yes Suture
3 41 F Micrognathia Chin 2.8 1 h 20 min 1y 1m e Yes Suture
4-1 23 M Right hemifacial microsomia Chin 3 2 h 5 min 3y e Yes No ﬁxed
4-2 Right mandibule 6.6 1y 2m No ﬁxed
5 23 F Left hemifacial microsomia Left mandibule 3.8 2 h 1y 1m e Yes No ﬁxed
6 30 F Right mandibular deformity after reconstruction Right mandibule 12.9 2 h 27 min 6y 6m e Yes Suture
7 53 F Left mandibular deformity after reconstruction Left mandibule 3.5 2 h 46 min 6y 5m e Yes Suture
8 18 F Micrognathia Chin 1.6 1 h 30 min 5y 8m e Yes Suture
9 38 F Left mandibular hypoplasia Left mandibule 2.4 1 h 36 min 2y e Yes No ﬁxed
10 43 F Mandibular deformity after trauma Chin 1.3 1 h 30 min 6y 2y e Yes Suture
11 44 M Mandibular deformity after reconstruction Both mandibule 8.4 5 h 18 min e 1y 6m No Suture
12 26 M Micrognathia Chin 1.1 2 h 16 min 1y e Yes Suture
13-1 32 F Mandibular deformity after reconstruction Right mandibule 0.8 4 h 13 min 1y e Yes Suture
13-2 Left mandibule 1.2 5y 11m Suture
14 26 M Right mandibular hypoplasia Right mandibule 2.5 2 h 23 min 1y e Yes Suture
15 30 F Right frontal bone deformity after reconstraction Right frontal bone 3 3 h 16 min e e Yes No ﬁxed
16 24 M Right hemifacial microsomia Right mandibule 2.1 2 h 50 min 1y e Yes Suture
17 20 F Right maxillary deformity after trauma Right maxilla 1.3 2 h 3y 11m e Yes Suture
18 20 F Treacher Collins' syndrome Chin 2.9 1 h 48 min 3y 9m e Yes Suture
19 39 F Left maxillary deformity after reconstruction Left maxilla 1.6 4 h 1y e Yes Suture
20 23 M Micrognathia Chin 2.4 2 h 12 min 1y e No Suture
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The DICOM data of the immediate postoperative CT scan and
those taken at 1e7 years, 3 months (3 years, 1 month on average)
postoperatively were output to zioTerm2009® (Ziosoft, Japan) for
evaluation of the changes in the CT-bones and the recipient bones.
In order to evaluate the deformities of the CT-bones, cross-sectional
images of the CT-bones vertical to the recipient bones were
generated for thickness measurement. In addition, for evaluation of
the positional relationship between the recipient bones and the CT-
bones, cross-sectional images of the CT-bones and the recipient
bones were generated on a plane vertical to the recipient bones for
measurement of the thickness for totaling the recipient bone and
the CT-bone. This measurement was also expected to provide in-
formation on resorption of the host bones, if the size of the CT-bone
had not changed. For the evaluation of the cross sections,
anatomical structures such as the mental foramina, coronoid pro-
cesses of the mandible, condyles in the mandibles and anterior/
posterior nasal spine, external acoustic foramina, and basion in the
maxilla were used as the landmarks for matching in the measure-
ment. Based on these images, the thickness was measured imme-
diately after surgery and at the maximal follow-up; the percent
change was calculated based on the thickness of the change to the
original thickness. Additionally, on this cross section, the union
between the CT-bone and the recipient bone was evaluated. The
bone union was judged present when the border between the CT-
bone and the recipient bone fully or partially showed CT values
equivalent to or higher than that of the cancellous bone, and
missing when the border did not show any sites with the CT values
equivalent to the cancellous bone. Moreover, the interior CT values
of the CT-bones were measured and compared between the
different time points. Three points from the interior of the CT-bone
on an identical cross section were used for the measurement, and
the mean value was adopted (Fig. 1).3. Results
Compatibility in the shapes between the CT-bone (0.8e15.8ml in
volume, Table 1) and the recipient bonewas goodduring the surgeryat all 23 sites of the 20 cases, while the CT-bones were conﬁrmed to
be easily installed onto the recipient sites. The operating timeswere
1 h, 20min; 5 h,18min; and 2h, 29min for the shortest, longest, and
average, respectively (Table 1). No serious systemic event due to the
CT-bone graft was found during the observation period (post-
operative1year). In one case (Case3), therewas anaccident inwhich
a handle of an umbrella signiﬁcantly hit the mental region due to a
strong wind at 1 month postoperatively, causing damage to the CT-
bone engrafted in the region. For this reason, the patient underwent
re-graft of a CT-bone under local anesthesia at 1 month post-
operativelywith no subsequent problem. A female patient (Case 15)
did not undergo a CT scan after she was found to be pregnant 2
months postoperatively. In 18 out of 20 cases, the patients were
satisﬁed with their results at 1 year postoperatively (Table 1).
At the 4 sites in 4 patients among the 23 sites of 20 patients, the
CT-bones were removed due to local infection of the grafting sites
(Case 1-2, Case 4-2: Fig. 2, Case 11 and Case 13-2: Fig. 3). The timing
of the removal was at 1 year to 2 years postoperatively in three
cases, and over 5 years postoperatively in one case. The causative
bacteria were Pseudomonas aeruginosa in two patients (Case 1-2,
Case 4-2), MRSA in one patient (Case 11), and unknown in one
patient (Case 13-2). One patient (Case 11) had a single graft,
whereas the other three patients (Case 1-2, Case 4-2, Case 13-2)
involved one site out of two graft sites. Suture of the CT-bones to
the host bones was performed at two sites (Case 1-2 and Case 4-2),
but not in the others (Case 11 and Case 13-2).
CT images were taken at 1 year postoperatively or thereafter in
all cases excluding two cases, in which pregnancy was found (Case
15) and in which the patient did not desire to undergo a CT scan
(Case 11) (21 sites of 18 patients in Table 1). The shortest and
longest follow-up periods were 1 year and 7 years, 3 months,
respectively. During this period, the maximum and minimum
thicknesses of the CT-bones were 2.26 and 13.0 mm, respectively
(Fig. 4). No clear chronological change was seen in the shape of the
CT-bones. The percent of change in the thickness of the CT-bones
was þ3.3% on average (min. 13.0%, max. þ30.8%). The ratio
increasedmore than 5% at 6 sites, decreasedmore than 5% at 2 sites,
and the change ranged within 5% at 13 sites, showing no apparent
chronological change in thickness at most sites. In Case 4-2 (Fig. 2),
Fig. 1. Interior CT values of the CT-bones. The CT values and the thickness totaling the
host bone and the CT-bone were measured (Case1-1). a: Immediately after surgery. b:
7 years and 3 months after surgery.
Fig. 2. The site in which the CT-bone was removed (Case4-2). a: Immediately after surger
totaling the CT-bone and the recipient bone decreased by 4.8% at 1 year after surgery. A re
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CT scanning. It was 1 of the 4 sites in which the CT-bones were
eventually removed.
To evaluate the positional relationship between the CT-bones
and the host bones, and to speculate about the occurrence of the
host bone resorption, changes in thickness totaling the CT-bone and
the host bone were evaluated. During the follow-up period, the
maximum and minimum values of the total thickness were 39.6
and 10.7 mm, respectively (Fig. 5). The percent of change was1.6%
on average (min. 19.4%, max. þ5.2%). The ratio increased more
than 5% at 1 site (e.g. 5.2% in Case 13-2, Fig. 3), decreased more than
5% at two sites, and the change was ranged within 5% at 18 sites. .
In Case 13-2, the increase in thickness was not a consequence of
the bone formation, but due to detachment of the CT-bone from the
recipient site (Fig. 5). It also occurred at 1 of 4 sites resulting in
removal of the graft.
In 18 of the 21 sites, in which the CT-bones remained at 1 year
postoperatively, bone unions were judged present by the CT images
(e.g. Case 9: Fig. 6, Case 14: Fig. 7). On the other hand, in 3 sites
(Case 1-2, Case 4-2 and Case 13-2), the bone unions were judged
missing. The interior CT values of the CT-bones increased
(1217/ 1522 on average) in all the sites (Fig. 8).
There was a trend that the longer the postoperative period, the
higher the CT value, although the ratio of increase seemed to be
reduced over the long term.4. Discussion
Although no serious systemic event caused by the CT-bone graft
was found in all of the 20 cases, infection resulted in the removal of
the CT-bone in 4 out of the 23 sites (Case 1, Case 4, Case 11, Case 13)
after more than 1 year after the operations. We diagnosed that the
inﬂammation at the sites of implantation was caused by infection,
but not by delayed foreign reaction. As the transplantation sites of
CT-bone showed the infection symptoms including of swelling,
local heat, reddish, ﬁstula and pus, and in some sites, we detected
bacteria including MRSA, we thought that infection but not foreign
body reaction occurred. The 3 patient (Case 1, Case 4, Case 13) out of
4, were satisﬁed comprehensively although the CT-bones wasy. b: 1 year after surgery. The thickness of CT bone was 13.0 mm, while the thickness
sorption of the recipient bone was observed (arrow).
Fig. 3. Another site in which the CT-bone was removed (Case13-2). a: Immediately after surgery. b: 1 year after surgery. The thickness totaling the CT-bone and the recipient bone
increased 5.2% at 1 year after surgery, suggesting ﬂoating of the CT-bone (arrow).
Fig. 4. Thicknesses of the CT-bones. The maximum and minimum thicknesses of the
CT-bones were 13.0 and 2.26 mm, respectively, and no clear chronological change was
seen in the shape of the CT-bones. The percent change in the thickness of the CT-bones
was þ3.3% on average (min. 13.0%, max. þ30.8%).
Fig. 5. Total thicknesses of the CT-bone and the host bone. The maximum and mini-
mum values of the total thickness were 38.9 and 10.7 mm, respectively. The ratio of
change was 1.7% on average (min. 19.4%, max. þ5.2%).
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into 2 sites. It was probably due to partial improvement of facial
appearance with the surviving CT-bones. In 1 patient (Case 11), the
CT-bonewas removed due to an infectionwithMRSA, as the patient
was a carrier of MRSA. After this incident, we determined to make a
carrier of MRSA a contraindication in principle for the casesthereafter. Moreover, other sites involving the CT-bone removal
also included cases in which the CT-bone was relatively thick
(13.0 mm in Case 4-2, Fig. 2). It is likely that the excessive height of
the CT-bone in contact with the recipient bone caused an unex-
pected mobility and instability of the CT-bone, creating a condition
Fig. 6. A case in which new bone formation was observed, particularly in the junctions between the recipient bones and the CT-bones (Case 9). a: Immediately after surgery. b: 2
years and 2 months after surgery. The total thickness had not drastically changed, and there was no resorption on the recipient bone. Union of the CT-bone and the recipient bone
was observed (arrow).
Fig. 7. Another case in which new bone formation was observed, particularly in the junctions between the recipient bones and the CT-bones (Case 14). a: Immediately after surgery.
b: 2 years after surgery. A new bone formation and improvement of compatibility were clearly observed, as indicated by the arrow.
Y. Kanno et al. / Regenerative Therapy 5 (2016) 1e86susceptible to infection associated with friable granulation. As large
size of CT-bone may be needed for severe bone deformity, we do
not make a limitation of volume in the CT-bone. Instead of it, we
adopted a design avoiding any excessive height in contact with the
recipient bone in subsequent cases. Thereafter, we avoided the
design in which the ratio of the CT-bone height to the width of the
minor axis in the contact area was greater than 0.6.
Although there was not the correlation between the removal
and the ﬁxation of the artiﬁcial bone using absorbable sutures, we
have an impression that the ﬁxation on the recipient bones
contributed to suppressing the incidence of a postoperativeinfection. In intraoral approach, the ﬁxations of CT-bone to lower
edge of mandible were rather difﬁcult. We did not ﬁx the CT-bone
onto host bone in some initial cases. However, in other cases,
considering the importance of ﬁxation, we tied the CT-bones to
host bones with absorbable sutures, bymaking suture holes in both
one side of cortical bone of mandible and CT-bone. It was possible
to provide CT-bones with internal structures because they are
fabricated by a three-dimensional layered manufacturing process
using inkjet printing. Indeed, we designed holes to be used for
ﬁxation by the absorbable sutures at the sites with a high strength,
and successfully formed the holes during the present study.
Fig. 8. Changes in CT values. The interior CT values of the CT-bones increased at all
sites.
Y. Kanno et al. / Regenerative Therapy 5 (2016) 1e8 7Artiﬁcial bones using a-TCP powder as the raw material are known
to become amorphous HA in vivo [16]. As the CT-bones are char-
acterized by a low crystallinity and fragility, it is difﬁcult to form
holes within the body by drilling. Therefore, it was an important
point in the manufacturing process to in advance provide internal
structures when required.
The thickness including both the artiﬁcial and host bones
measured on a synchronized cross section in the CT images showed
little change. One out of the four cases of the CT-bone removal
showed an increase in the thickness by 5.2% (Case13-2, Fig. 3). This
was likely associated with the ﬂoating of the CT-bones caused by
insufﬁcient union with the recipient bones. Though the total
thickness decreased in another case with graft removal (Case4-2,
Fig. 2) by 4.8%, the thickness of the CT-bone did not decrease. The
host bone resorption was detected in this case. In Case 7, the
thickness remarkably decreased by 19%. However, this seemed to
be due to the partial ﬂoating of the CT-bone that became separated
from the host bone immediately after the grafting, which improved
with time.
The CT images at 1 year postoperatively showed a satisfactory
union between the bones at 18 sites, excluding 3 sites where the CT-
bone was removed. As new bone formation was remarkable at
these sites, particularly in the junctions between the recipient
bones and the CT-bones (Figs. 6 and 7), we conﬁrmed that this
artiﬁcial bone had a sufﬁcient osteoconductivity. In the 3 cases in
which the CT-bone was removed, the bone union between host
bone and CT-bone was not observed at 1 year postoperatively. We
supposed that instability of CT-bone should facilitate infection. We
consider that bone union between host bone and CT-bone is
important for the success of this treatment.
The unions started to be detected half a year postoperatively in
some cases, which is relatively early even in comparison with
conventional custom-made artiﬁcial bones [17]. This is likely
because the CT-bones made from unsintered HA are easily replaced
by living bones and superior in biological activity [18]. We thinkthat some of a-TCP change to amorphous calcium-deﬁcient HA, just
after the hydration of a-TCP powder by binding solution of inkjet.
Being different from conventional artiﬁcial bone made by sintered
HA, the CT-bone is likely to have better biodegradability, enhancing
bone formation.
In the follow-up period, the CT value of the interior of the
artiﬁcial bone increased at all of the 21 sites (1217 / 1522 on
average), including 3 sites where the CT-bone was removed. There
is no signiﬁcant difference between place of CT-bones, as shown in
Fig. 8. According to Misch CED [19], the CT values of the mandible
are 100e2000 (cancellous bone, 100e400; cortical bone,
1500e2000). It is likely that the CT-bones had changed, having
similar CT values to that of the mandibular cortical bone. Based on
these results, we assumed that these CT-bones function as scaffolds
for cells migrating from the local vicinity, leading to new bone
formation in the interior of the artiﬁcial bones. Moreover, some of
the cases showed a trend inwhich the CT values of the periphery of
the artiﬁcial bones increased. Considering the fact that the peri-
osteum of physiological bones induces membranous ossiﬁcation of
adjacent cortical bones, a periosteum-like tissuewith an osteogenic
capacity might be formed around the CT-bones. Silicone onlay
grafts performed in cosmetic surgery are known to frequently cause
bone resorption [20]. Sintered HA also causes a similar phenome-
non according to a previous report [21].
In the present study, the thickness totaling the CT-bones and
recipient bones decreased only slightly on average (1.6%),
increased at 8 out of 21 sites, one of which prominently showed
new bone formation even on the surface of the CT-bone (data not
shown). Thus, the CT-bones were unlikely to cause severe host bone
resorption; the CT-bones have a sufﬁcient osteoconductivity
compared to silicone implants and sintered HA.
The CT-bone was developed with the expectation of early bone
replacement, because unsintered HA is the major component.
Nevertheless, complete replacement was not found even in the case
7 years and 3 months of the longest follow-up, although new bone
formation was partly seen inside of the CT-bone. Further observa-
tion is needed to determine whether the CT-bone can be totally
replaced by physiological bone.
With regard to future prospects, we are making efforts in
development/application of an intelligent type of artiﬁcial bones in
which bone regeneration is induced by gradually releasing angio-
genic factors and/or osteogenic factors at the three-dimensionally
controlled positions through inkjet printing of these bioactive
molecules from the printer head. Moreover, as the fabrication
method for CT-bones can provide complicated shapes such as in-
ternal structures, it is likely to become possible to provide such
structures promoting cellular migration and/or angiogenesis. We
believe that this will allow more rapid bone union or replacement.Conﬂict of interest
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